Definitive Contract FA805220C0018

Award Date 9/30/20
Potential Completion Date 9/29/21
Potential Value $33M
Funding Federal Agency
District Washington
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
This firm fixed price purchase order was awarded by the Department of the Air Force Air Education and Training Command to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $269,500 contract is for the delivery of the BioFire FA TORCH Base System and associated modules for COVID-19 testing, with performance occurring in Emigration Canyon, Utah. Biofire Defense has a history of providing diagnostic systems, testing kits, and...
The Defense Health Agency (DOD) awarded a $742,431.36 firm fixed price purchase order to Biofire Defense LLC of Salt Lake City, Utah. The contract is to provide Respiratory Panel 2.1 In Vitro Diagnostic tests from November 7, 2022 through January 11, 2023. Biofire Defense LLC will deliver their Biofire Respiratory Panel 2.1 tests, which can rapidly detect more than twenty common respiratory pathogens including influenza A and B, respiratory syncytial virus, rhinovirus/enterovirus, coronavirus...
This contract was awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for 40 respiratory panels at a firm fixed price of $162,285.00, to be delivered by October 15, 2021. The respiratory panels are used to detect respiratory pathogens, including SARS-CoV-2. This contract does not have a set-aside designation. Biofire Defense has previously provided diagnostic assays, test...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $3 million firm fixed price delivery order contract to Biofire Defense LLC of Salt Lake City, Utah. Under the terms of the contract, Biofire Defense will provide commercial assay kits for the RP2.1 assays and COVID-19 assay external control materials to support the Department's coronavirus COVID-19 response efforts. The contract runs from April 24, 2020 through October 31, 2020 and...
The Department of the Air Force Defense Finance and Accounting Service awarded a $295,000 firm fixed price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of a system capable of performing syndromic infectious disease testing using Biofire reagents, specifically the Biofire Torch system which can process 12 tests simultaneously in 1 hour. This contract does not have a...
This is a firm fixed-price purchase order awarded by the Air Combat Command (ACC) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company based in Salt Lake City, Utah. The $434,982.96 contract is for the provision of Biofire's FilmArray diagnostic systems, COVID-19 testing reagents, infectious disease testing panels, equipment maintenance services, and cost-per-test diagnostic solutions. The contract does not have a set-aside designation, indicating open competition....
This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Biofire Diagnostics, LLC for $628,560. The contract is for 194 tests of Biofire's RP2.1 panel, with 30 tests per kit, to support COVID-19 testing. The place of performance is Emigration Canyon, Utah, with a period of performance from November 2020 through February 2022. The solicitation sought these Biofire COVID-19 test kits on a sole...
This is a $225,000.00 firm fixed price purchase order awarded by the Department of the Air Force Materiel Command to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of Biofire TORCH FilmArray COVID-19 testing equipment to the 78th Medical Group at Robins Air Force Base in Georgia. This award supports the Coronavirus COVID-19 national interest action and does not have a set-aside...
The Department of the Air Force Air Mobility Command awarded a Firm Fixed Price delivery order contract to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $278,479.60 contract is for the provision of Film Array Network Kits and Instruments to support the national response to the Coronavirus (COVID-19) pandemic. This work is being conducted under a Multiple Award Schedule contract vehicle, with no set-aside designation....

The Department of the Air Force awarded a definitive contract valued at $33.1 million to Biofire Defense LLC of Salt Lake City, Utah. The firm fixed price contract is to provide "COVID 19" BIOFIRE RESPIRATORY 2.1 (RP2.1) PANEL WITH SARS_COV-2 diagnostic testing kits compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. The solicitation sought proposals to supply these BioFire Respiratory 2.1 panels to detect SARS-CoV-2 and 21 additional respiratory pathogens for distribution to 74 Department of the Air Force medical treatment facilities over a one year period under an indefinite-delivery/indefinite-quantity contract. There was no set-aside designation for this requirement to support the Department's medical response to the coronavirus pandemic.

Generated 12/29/23, 4:23 PM